+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

From
Vasculitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Vasculitis Treatment - Global Strategic Business Report

  • Report
  • November 2024
  • 183 Pages
  • Global
From
From
From
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 179 Pages
  • Global
From
Renal cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Renal cell carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Gastrointestinal Endoscopy Global Market Report 2024 - Product Thumbnail Image

Gastrointestinal Endoscopy Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Cell Therapy Clinical Activity and Process Automation - Product Thumbnail Image

Cell Therapy Clinical Activity and Process Automation

  • Report
  • July 2023
  • 100 Pages
  • Global
From
Allergy Treatment Global Market Report 2024 - Product Thumbnail Image

Allergy Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator